• Corpus ID: 40582966

EDIBLE MUSHROOMS AS POTENTIAL SOURCES OF NEW HYPOCHOLESTEROLEMIC COMPOUNDS

@inproceedings{GilRamrez2011EDIBLEMA,
  title={EDIBLE MUSHROOMS AS POTENTIAL SOURCES OF NEW HYPOCHOLESTEROLEMIC COMPOUNDS},
  author={Alicia Gil-Ram{\'i}rez and Cristina Nohora Madiedo Clavijo and Marimuthu Palanisamy and Cristina Soler-Rivas and Alejandro Ru{\'i}z-Rodr{\'i}guez and Francisco R. Marin and Guillermo Reglero and Margarita P{\'e}rez},
  year={2011}
}
Coronary heart disease (CHD) is the leading cause of death in the Western world after cancer according to World Health Organization. Many studies have established that high totalcholesterol levels and low-density lipoprotein (LDL) cholesterol levels are risk factors for CHD and mortality. Many investigations have been carried out to explore the possibility of increasing components which have hypocholesterolemic effects in the diet. Two particular groups of substances phytosterols and β-glucans… 

Figures and Tables from this paper

Therapeutic properties of Pleurotus species (oyster mushrooms) for atherosclerosis: A review
ABSTRACT Atherosclerosis is an impairment of the artery walls made up of two membrane layers, intima and media. Oxidative stress, hypertension, and hypercholesterolemia are the three main factors
Evaluation of the Antioxidative and Hypo-cholesterolemic Effects of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), in Ameliorating Cardiovascular Disease.
TLDR
The current findings indicate the therapeutic potentiality of G. lucidum as an OS-attenuating and hypocholesterolemic agent en route to withstanding CVD complications.
Biomolecules of mushroom: a recipe of human wellness
TLDR
The current status of the medicinal attributes of mushrooms and their biomolecules in different diseases such as cardiovascular, diabetes, reproductive diseases, cancer, and neurodegenerative diseases are reviewed.
Extraction of bioactive compounds against cardiovascular diseases from Lentinula edodes using a sequential extraction method
TLDR
Water soluble fractions from Lentinula edodes (shiitake mushrooms) containing bioactive compounds against cardiovascular diseases (CVDs) showed high antioxidant activities and were able to inhibit one of the main enzymes involved in hypertension and the key enzyme of cholesterol metabolism.
Evaluation of Polish Wild Mushrooms as Beta-Glucan Sources
TLDR
Wild mushrooms are indicated as interesting material for β-glucan extraction for food industry and medicinal purposes because of their immunomodulatory, anticancer and antioxidant features.
Edible Ectomycorrhizal Mushrooms: Biofactories for Sustainable Development
TLDR
Despite the fact that most EEMs have defied cultivation, some advances have been made in cultivation of truffles and broth cultures of species included in the genera Hygrophorus, Lactarius, Morchella, Rhizopogon, Suillus, and Tuber as a potential source of bioactive compounds with medical or nutraceutical importance.
Study on the 3-hydroxy-3-methyl-glutaryl CoA reductase inhibitory properties of Agaricus bisporus and extraction of bioactive fractions using pressurised solvent technologies.
TLDR
A mushroom cultivation and two extraction procedures were optimised to obtain fractions from A. bisporus with high HMGCR inhibitory activities to design novel ingredients for hypocholesterolaemic functional foodstuffs.
Interpretation of mushroom as a common therapeutic agent for Alzheimer’s disease and cardiovascular diseases
TLDR
This review interprets the polypharmaceutic role of mushrooms treating AD and CVD and finds mushroom bio-components may be promising in controlling both diseases.
...
...

References

SHOWING 1-10 OF 32 REFERENCES
Evidence for the anti-hyperlipidaemic activity of the edible fungus Pleurotus ostreatus.
TLDR
A significantly increased phospholipid-to-cholesterol ratio in the aortas of both groups of rats, after the administration of either dried oyster fungus or the ethanolic extract of it, suggests a favourable anti-atherogenic effect for both.
Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs
TLDR
Overall, Gl has potential to reduce LDL cholesterol in vivo through various mechanisms and next steps are to fully characterize bioactive components in lipid soluble/insoluble fractions and evaluate bioactivity of isolated fractions.
Effect of hypolipidemic drugs on key enzyme activities related to lipid metabolism in normolipidemic rabbits.
...
...